983 related articles for article (PubMed ID: 28322168)
1. Pediatric Off-Label and Unlicensed Drug Use and Its Implications.
Gore R; Chugh PK; Tripathi CD; Lhamo Y; Gautam S
Curr Clin Pharmacol; 2017; 12(1):18-25. PubMed ID: 28322168
[TBL] [Abstract][Full Text] [Related]
2. Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature.
Lindell-Osuagwu L; Korhonen MJ; Saano S; Helin-Tanninen M; Naaranlahti T; Kokki H
J Clin Pharm Ther; 2009 Jun; 34(3):277-87. PubMed ID: 19650250
[TBL] [Abstract][Full Text] [Related]
3. Unlicensed and off-label drug use in children: implications for safety.
Choonara I; Conroy S
Drug Saf; 2002; 25(1):1-5. PubMed ID: 11820908
[TBL] [Abstract][Full Text] [Related]
4. Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety.
Cuzzolin L; Atzei A; Fanos V
Expert Opin Drug Saf; 2006 Sep; 5(5):703-18. PubMed ID: 16907660
[TBL] [Abstract][Full Text] [Related]
5. [Off-label and unlicensed drug use: Results from a pilot study in a pediatric intensive care unit].
García-López I; Fuentes-Ríos JE; Manrique-Rodríguez S; M Fernández-Llamazares C
An Pediatr (Barc); 2017 Jan; 86(1):28-36. PubMed ID: 27151379
[TBL] [Abstract][Full Text] [Related]
6. The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients.
Neubert A; Dormann H; Weiss J; Egger T; Criegee-Rieck M; Rascher W; Brune K; Hinz B
Drug Saf; 2004; 27(13):1059-67. PubMed ID: 15471510
[TBL] [Abstract][Full Text] [Related]
7. Off-Label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter Study.
Pratico AD; Longo L; Mansueto S; Gozzo L; Barberi I; Tiralongo V; Salvo V; Falsaperla R; Vitaliti G; La Rosa M; Leonardi S; Rotondo A; Avola N; Sgarlata D; Damiano A; Tirantello M; Anzelmo G; Cipolla D; Rizzo A; Russo A; Ruggieri M; Salomone S; Drago F
Curr Drug Saf; 2018; 13(3):200-207. PubMed ID: 29921210
[TBL] [Abstract][Full Text] [Related]
8. Off-label and unlicensed utilisation of medicines in a French paediatric hospital.
Joret-Descout P; Prot-Labarthe S; Brion F; Bataille J; Hartmann JF; Bourdon O
Int J Clin Pharm; 2015 Dec; 37(6):1222-7. PubMed ID: 26394784
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of unlicensed and off-label antiepileptic drugs prescribed to children: Brazilian Regulatory Agency versus FDA.
Borges AP; Campos MS; Pereira LR
Int J Clin Pharm; 2013 Jun; 35(3):425-31. PubMed ID: 23430533
[TBL] [Abstract][Full Text] [Related]
10. Unlicensed and Off-Label Medication Use in Pediatric and Neonatal Intensive Care Units: No Change Over a Decade.
Nir-Neuman H; Abu-Kishk I; Toledano M; Heyman E; Ziv-Baran T; Berkovitch M
Adv Ther; 2018 Jul; 35(7):1122-1132. PubMed ID: 29949042
[TBL] [Abstract][Full Text] [Related]
11. Unlicensed and off-label use of medicines in children admitted to the intensive care units of a hospital in Malaysia.
Lee JL; Redzuan AM; Shah NM
Int J Clin Pharm; 2013 Dec; 35(6):1025-9. PubMed ID: 24022725
[TBL] [Abstract][Full Text] [Related]
12. Comparative Assessment of Off-label and Unlicensed Drug Prescriptions in Children: FDA Versus ANSM Guidelines.
Berdkan S; Rabbaa L; Hajj A; Eid B; Jabbour H; Osta NE; Karam L; Khabbaz LR
Clin Ther; 2016 Aug; 38(8):1833-44. PubMed ID: 27392716
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of off-label and unlicensed paediatric prescribing in a hospital in Indonesia during the period Aug.-Oct. 2014.
Tukayo BLA; Sunderland B; Parsons R; Czarniak P
PLoS One; 2020; 15(1):e0227687. PubMed ID: 31935254
[TBL] [Abstract][Full Text] [Related]
14. Off-label and unlicensed drug use among neonatal intensive care units in Southern Italy.
Laforgia N; Nuccio MM; Schettini F; Dell'Aera M; Gasbarro AR; Dell'Erba A; Solarino B
Pediatr Int; 2014 Feb; 56(1):57-9. PubMed ID: 23937449
[TBL] [Abstract][Full Text] [Related]
15. Unlicensed and off-label use of drugs in pediatric surgical units at tertiary care hospitals of Pakistan.
Aamir M; Khan JA; Shakeel F; Asim SM
Int J Clin Pharm; 2017 Aug; 39(4):860-866. PubMed ID: 28597174
[TBL] [Abstract][Full Text] [Related]
16. Unlicensed and off-label medication use in a general pediatrics ambulatory hospital unit in Israel.
Gavrilov V; Lifshitz M; Levy J; Gorodischer R
Isr Med Assoc J; 2000 Aug; 2(8):595-7. PubMed ID: 10979352
[TBL] [Abstract][Full Text] [Related]
17. Healthcare professional experiences and attitudes on unlicensed/off-label paediatric prescribing and paediatric clinical trials.
Mukattash T; Hawwa AF; Trew K; McElnay JC
Eur J Clin Pharmacol; 2011 May; 67(5):449-61. PubMed ID: 21243345
[TBL] [Abstract][Full Text] [Related]
18. Unlicensed and off-label drug use in hospitalized children in Croatia: a cross-sectional survey.
Palčevski G; Skočibušić N; Vlahović-Palčevski V
Eur J Clin Pharmacol; 2012 Jul; 68(7):1073-7. PubMed ID: 22307225
[TBL] [Abstract][Full Text] [Related]
19. Adverse Drug Reactions in Children: The Double-Edged Sword of Therapeutics.
Elzagallaai AA; Greff M; Rieder MJ
Clin Pharmacol Ther; 2017 Jun; 101(6):725-735. PubMed ID: 28295234
[TBL] [Abstract][Full Text] [Related]
20. Adverse drug reactions and off-label and unlicensed medicines in children: a prospective cohort study of unplanned admissions to a paediatric hospital.
Bellis JR; Kirkham JJ; Nunn AJ; Pirmohamed M
Br J Clin Pharmacol; 2014 Mar; 77(3):545-53. PubMed ID: 23919928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
